Characteristics of Treatment Responders to Galantamine

• Status: Completed
• Trial end date: 2009-10-01

Summary

To investigate the characteristics of treatment responders to galantamine.

• Phase: N/A

Details

• Lead Sponsor: Samsung Medical Center
• Collaborator: Janssen Korea, Ltd., Korea
• Treatments: Galantamine